Potential role of endothelin-1 and endothelin antagonists in cardiovascular diseases

Basic Research in Cardiology

Volumn 95, Issue 4, 2000, Pages 290-298

  Schmitz Spanke, Simone ^a   Schipke, J D ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Cardiovascular system; Endothelin; Pathophysiology; Physiology; Receptor

Indexed keywords

BOSENTAN; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); DARUSENTAN; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENDOTHELIN 1; ENDOTHELIN 2; ENDOTHELIN 3; ENDOTHELIN A RECEPTOR; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR; ENDOTHELIN B RECEPTOR ANTAGONIST; ENDOTHELIN CONVERTING ENZYME INHIBITOR; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; N ACETYL 10,11 DIHYDRO 5H DIBENZO[A,D]CYCLOHEPTEN 5 YLGLYCYLLEUCYLASPARTYLISOLEUCYLISOLEUCYLTRYPTOPHAN; PHOSPHORAMIDON;

ANGIOGENESIS; ATHEROSCLEROSIS; BLOOD VESSEL PERMEABILITY; BRONCHUS STENOSIS; CARDIOVASCULAR DISEASE; CELL ADHESION; CHRONIC KIDNEY FAILURE; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; DRUG SYNTHESIS; EMBRYO DEVELOPMENT; ESSENTIAL HYPERTENSION; HEART INFARCTION; MIGRAINE; NONHUMAN; POSTNATAL GROWTH; PULMONARY HYPERTENSION; RESTENOSIS; REVIEW; THROMBOGENESIS; VASOCONSTRICTION;

ANIMALS; CALCIUM CHANNELS, L-TYPE; CORONARY DISEASE; ENDOTHELIN-1; HUMANS; HYPERTENSION; RECEPTOR, ENDOTHELIN A; RECEPTOR, ENDOTHELIN B; RECEPTORS, ENDOTHELIN;

EID: 0033841865     PISSN: 03008428     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003950070048     Document Type: Review

References (87)

1. Control of coronary blood flow by autocoids
2. Mechanisms and prevention of restenosis: From experimental models to clinical practice
3. Inotropic effects of endothelin-1: Interaction with molsidomine and with BQ 610
4. ET-1 stimulates Ca2+ currents in cardiac cells
5. Endothelin-converting enzyme-1 mRNA expression in human cardiovascular disease
6. Role of endothelin in the increased vascular tone of patients with essential hypertension
7. Additional hypotensive effect of endothelin-1 receptor antagonism in hypertensive dogs under angiotensin-converting enzyme inhibition
8. Endothelin receptor subtypes are coupled to adenylate cyclase via different guanyl nucleotide-binding proteins in vasculature
9. 2+ transients and contractility in rabbit ventricular myocardium
10. Differential inhibitory action of phorbol-12,13-dibutyrate on the positive inotropic effect of endothelin-1 and Bay K 8644 in the isolated rabbit papillary muscle
11. Endothelin-1-induced myocardial ischaemia and oedema in the rat: Involvement of the ET(A) receptor, platelet-activating factor and thromboxane A2
12. Effect of endothelin on the function of the isolated perfused working rat heart
13. Chronic endothelin receptor blockade attenuates progressive ventricular dilation and improves cardiac function in rats with myocardial infarction: Possible involvement of myocardial endothelin system in ventricular remodeling
14. Natriuretic peptides inhibit angiotensin II-induced proliferation of rat cardiac fibroblasts by blocking endothelin-1 gene expression
15. Expression of endothelin-1 and endothelin-converting enzyme-1 mRNAs and proteins in failing human hearts
16. Clearance of circulating endothelin-1 by ET(B) receptors in rats
17. Effects of endothelin-1 and the ET(A)-receptor antagonist, BQ123, on ischemic arrhythmias in anesthetized rats
18. The endothelin system and its potential as a therapeutic target in cardiovascular disease
19. Inotropic drugs, calcium, phosphodiesterase inhibitors
20. Reduced endogenous endothelin-1-mediated vascular tone in chronic renal failure
21. ICAM-1 expression on cardiac myocytes and aortic endothelial cells via their specific endothelin receptor subtype
22. Endothelin as a regulator of cardiovascular function in health and disease
23. Distinct tissue distribution and cellular localization of two messenger ribonucleic acids encoding different subtypes of rat endothelin receptors
24. Targeted and natural (piebald-lethal) mutations of endothelin-B receptor gene produce megacolon associated with spotted coat color in mice
25. Hypoxia regulates expression of the endothelin-1 gene through a proximal hypoxia-inducible factor-1 binding site on the antisense strand
26. Aggravation of left ventricular remodeling by a novel specific endothelin ET(A) antagonist EMD94246 in rats with experimental myocardial infarction
27. Pathomorphology of coronary atherosclerosis
28. Mild hypoxia induces hypertrophy of cultured neonatal rat cardiomyocytes: A possible endogenous endothelin-1-mediated mechanism
29. Inhibition of the cardiac protein kinase A-dependent chloride conductance by endothelin-1
30. Low oxygen enhances endothelin-1 (ET-1) production and responsiveness to ET-1 in cultured cardiac myocytes
31. Cloning and characterization of an endothelin-3 specific receptor (ET(C) receptor) from Xenopus laevis dermal melanophores
32. Effects of endothelin on coronary flow, mechanical performance, oxygen uptake, and formation of purines and on outflow of prostacyclin in the isolated rabbit heart
33. Cardiac endothelin release and infarct size, myocardial blood flow, and ventricular function in canine infarction and reperfusion
34. 2+ current in ventricular cardiomyocytes
35. 2+ current in ventricular cardiomyocytes
36. + exchange in mediating effects of endothelin-1 on normal and ischemic/reperfused hearts
37. Endothelin and restenosis
38. Hypoxia induces endothelin gene expression and secretion in cultured human endothelium
39. + exchanger
40. The effect of an endothelin-receptor antagonist, bosentan, on blood pressure in patients with essential hypertension. Bosentan Hypertension Investigators
41. Elevated blood pressure and craniofacial abnormalities in mice deficient in endothelin-1
42. 2+ current by a G protein-dependent mechanism in rabbit cardiac myocytes
43. Vasodilator effects of endothelin-converting enzyme inhibition and endothelin ET(A) receptor blockade in chronic heart failure patients treated with ACE inhibitors
44. Local regulation of coronary circulation in health and disease: Role of nitric oxide and endothelin
45. Contrasting inotropic effects of endogenous endothelin in the normal and failing human heart: Studies with an intracoronary ET(A) receptor antagonist
46. Kinetics of vasoconstricor action of endothelins
47. Overview: Reduced sensitivity of vascular response to endothelin
48. Subcellular mechanisms of endothelin action in vascular system
49. Endothelin antagonist bosentan blocks neurogenic inflammation, but is not effective in aborting attacks
50. Pathophysiology of endothelin in the cardiovascular system
51. Neurohormonal markers of clinical outcome in cardiovascular disease: Is endothelin the best one?
52. Endothelin in hypertension: A role for receptor antagonists?
53. Selective ET(A) receptor blockade prevents left ventricular remodeling and deterioration of cardiac function in experimental heart failure
54. Role of endogenous endothelin in chronic heart failure: Effect of long-term treatment with an endothelin antagonist on survival, hemodynamics, and cardiac remodeling
55. Reduced responsiveness to endothelin-1 in peripheral resistance vessels of patients with syndrome X
56. Endothelin A receptor blockade causes adverse left ventricular remodeling but improves pulmonary artery pressure after infarction in the rat
57. The endothelium in acute coronary syndromes
58. Molecular cloning of a non-isopeptide-selective human endothelin receptor
59. Hemodynamic effect of endothelin antagonists in dogs with myocardial infarction
60. ET-receptor antagonism, myocardial gene expression, and ventricular remodeling during CHF in rats
61. Transient, isopeptide-specific induction of myocardial endothelin-1 mRNA in congestive heart failure in rats
62. Endothelin-A receptor mediates cardiac inhibition by regulating calcium and potassium currents
63. Transgenic rats as a model for investigation of the pathogenesis of hypertension
64. Coordinated upregulation of the cardiac endothelin system in a rat model of heart failure
65. Endothelins potentiate formalin-induced nociception and paw edema in mice
66. Role of cAMP and calcium influx in endothelin-1-induced ANP release in rat cardiomyocytes
67. Endothelin induced contractility of stellate cells from normal and cirrhotic rat liver: Implications for regulation of portal pressure and resistance
68. Potential physiological and pathological significance of endothelin
69. Endothelin-1 stimulates the biosynthesis of tumor necrosis factor in macrophages: ET-receptors, signal transduction and inhibition by dexamethasone
70. Endothelin peptide and converting enzymes in human endothelium
71. The effects of endothelin-A receptor blockade during the progression of pacing-induced congestive heart failure
72. Inhibition of myocardial endothelin pathway improves long-term survival in heart failure
73. Endogenous endothelin-1 participates in the maintenance of cardiac function in rats with congestive heart failure: Marked increase in endothelin-1 production in the failing heart
74. Die Rolle von Endothelin und Endothelinrezeptoren am isolierten Kaninchenherzen
75. Effects of Endothelin-1 on hemodynamics of anesthetized rabbits
76. Pharmacological profile of FR139317, a novel, potent endothelin ET(A) receptor antagonist
77. Short-term oral endothelin-receptor antagonist therapy in conventionally treated patients with symptomatic severe chronic heart failure
78. Role of endothelin in the maintenance of blood pressure in conscious rats with chronic heart failure - Acute effects of the endothelin receptor antagonist Ro 47-0203 (bosentan)
79. Calcium and the endothelin-1 and a1-adrenergic stimulated phosphatidylinositol cycle in cultured rat cardiomyocytes
80. Role of endothelin in a rabbit model of acute myocardial infarction: Effects of receptor antagonists
81. Endothelin ET(A) - Receptors couple to inositol phosphate formation and inhibition of adenylate cyclase in human right atrium
82. Hemodynamic and coronary effects of the endothelin antagonist bosentan in patients with coronary artery disease
83. 2+ signaling in guinea pig ventricular myocytes: Role of protein kinase C
84. Endothelin-1 is involved in mechanical stress-induced cardiomyocyte hypertrophy
85. A novel potent constrictor peptide produced by vascular endothelial cells
86. Tissue endothelin-1 immunoreactivity in the active coronary atherosclerotic plaque. A clue to the mechanism of increased vasoreactivity of the culprit lesion in unstable angina
87. Increased tissue endothelin immunoreactivity in atherosclerotic lesions associated with acute coronary syndromes